|
1
|
Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C and Russo P: Epidemiology of renal cell carcinoma. Eur Urol. 75:74–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Courthod G, Tucci M, Di Maio M and Scagliotti GV: Papillary renal cell carcinoma: A review of the current therapeutic landscape. Crit Rev Oncol Hematol. 96:100–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bellido JA, Palou J, Hübner M, Pascual M, Sagristá R, Martínez E, Martínez J, Rosales A and Villavicencio H: Early ultrasound detection of renal tumors in patients with end stage renal disease in dialysis. Arch Esp Urol. 60:1.079–1.083. 2007.(In Spanish). PubMed/NCBI
|
|
5
|
Tunio MA, Hashmi A and Rafi M: Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: A meta-analysis of randomized controlled trials. Ann Oncol. 21:1839–1845. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Wu G, Xu Y, Li J, Ruan N, Chen Y, Zhang Q and Xia Q: Porcupine inhibitor LGK974 downregulates the Wnt signaling pathway and inhibits clear cell renal cell carcinoma. Biomed Res Int. 2020:25276432020.PubMed/NCBI
|
|
7
|
Kovacs SB and Miao EA: Gasdermins: Effectors of pyroptosis. Trends Cell Biol. 27:673–684. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Broz P, Pelegrín P and Shao F: The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 20:143–157. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X and Tang Z: Role of gasdermin family proteins in cancers (review). Int J Oncol. 63:1002023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi J, Gao W and Shao F: Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 42:245–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan YY, Xie KX, Wang SL and Yuan LW: Inflammatory caspase-related pyroptosis: Mechanism, regulation and therapeutic potential for inflammatory bowel disease. Gastroenterol Rep (Oxf). 6:167–176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Liu X, Bai X, Lin Y, Li Z, Fu J, Li M, Zhao T, Yang H, Xu R, et al: Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 64:2018. View Article : Google Scholar
|
|
13
|
Zhao P, Wang M, Chen M, Chen Z, Peng X, Zhou F, Song J and Qu J: Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials. 254:1201422020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Li Y and Bai Y: Role of GSDMB in pyroptosis and cancer. Cancer Manag Res. 12:3033–3043. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, Yanagihara K, Tamura M, Mizushima H, Sakamoto H, et al: GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene. 26:6488–6498. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang WJ, Chen D, Jiang MZ, Xu B, Li XW, Chu Y, Zhang YJ, Mao R, Liang J and Fan DM: Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J Dig Dis. 19:74–83. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lutkowska A, Roszak A, Lianeri M, Sowińska A, Sotiri E and Jagodziński PP: Analysis of rs8067378 polymorphism in the risk of uterine cervical cancer from a polish population and its impact on gasdermin B expression. Mol Diagn Ther. 21:199–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miguchi M, Hinoi T, Shimomura M, Adachi T, Saito Y, Niitsu H, Kochi M, Sada H, Sotomaru Y, Ikenoue T, et al: Gasdermin C is upregulated by inactivation of transforming growth factor β receptor type II in the presence of mutated Apc, promoting colorectal cancer proliferation. PLoS One. 11:e01664222016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mu M, Yu Q, Zhang Q, Guo J, Wang X, Sun X and Yu J: A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins. Cancer Cell Int. 22:802022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li R, Wei H, Wang S, Huang Z, Chen H, Zhang S, Lin J and Zhong G: Gasdermin D expression and clinicopathologic outcome in primary osteosarcoma patients. Int J Clin Exp Pathol. 13:3149–3157. 2020.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen R, Zhang Z, Hu B, Jiang M, Zheng P, Deng W, Fu B and Sun T: Identification of the expression and clinical significance of E2F family in clear cell renal cell carcinoma. Int J Gen Med. 15:1193–1212. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45((W1)): W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C and Chanda SK: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10:15232019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu CJ, Hu FF, Xia MX, Han L, Zhang Q and Guo AY: GSCALite: A web server for gene set cancer analysis. Bioinformatics. 34:3771–3772. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al: Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41:(Database Issue). D955–961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, Ebright RY, Stewart ML, Ito D, Wang S, et al: An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell. 154:1151–1161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, et al: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. Genes Cancer. 1:152–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, et al: An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 173:400–416.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
T G S: Innate and adaptive immune cells in Tumor microenvironment. Gulf J Oncolog. 1:77–81. 2021.PubMed/NCBI
|
|
34
|
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, et al: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chevrier S, Levine JH, Zanotelli VRT, Silina K, Schulz D, Bacac M, Ries CH, Ailles L, Jewett MAS, Moch H, et al: An immune atlas of clear cell renal cell carcinoma. Cell. 169:736–749.e18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, Yu T, Wu X, Shi Y, Ma P and Shu Y: Pyroptosis: A new frontier in cancer. Biomed Pharmacother. 121:1095952020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu P, Chen X and Peng C: A new perspective in pyroptosis: Lifting the veil on GSDMA activation. Front Med. 17:581–583. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hergueta-Redondo M, Sarrio D, Molina-Crespo Á, Vicario R, Bernadó-Morales C, Martínez L, Rojo-Sebastián A, Serra-Musach J, Mota A, Martínez-Ramírez Á, et al: Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer. Oncotarget. 7:56295–56308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Komiyama H, Aoki A, Tanaka S, Maekawa H, Kato Y, Wada R, Maekawa T, Tamura M and Shiroishi T: Alu-derived cis-element regulates tumorigenesis-dependent gastric expression of GASDERMIN B (GSDMB). Genes Genet Syst. 85:75–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He H, Yi L, Zhang B, Yan B, Xiao M, Ren J, Zi D, Zhu L, Zhong Z, Zhao X, et al: USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway. Int J Biol Sci. 17:2417–2429. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cui Y, Zhou Z, Chai Y and Zhang Y: Upregulated GSDMB in clear cell renal cell carcinoma is associated with immune infiltrates and poor prognosis. J Immunol Res. 2021:77535532021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ruan J: Structural insight of gasdermin family driving pyroptotic cell death. Adv Exp Med Biol. 1172:189–205. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng S, Fox D and Man SM: Mechanisms of gasdermin family members in inflammasome signaling and cell death. J Mol Biol. 430:3068–3080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei J, Xu Z, Chen X, Wang X, Zeng S, Qian L, Yang X, Ou C, Lin W, Gong Z and Yan Y: Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma. Mol Med Rep. 21:360–370. 2020.PubMed/NCBI
|
|
45
|
Orning P, Lien E and Fitzgerald KA: Gasdermins and their role in immunity and inflammation. J Exp Med. 216:2453–2465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang YY, Liu XL and Zhao R: Induction of pyroptosis and its implications in cancer management. Front Oncol. 9:9712019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T and Song Y: Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non-small cell lung cancer. Oncol Rep. 40:1971–1984. 2018.PubMed/NCBI
|
|
48
|
Wang Y, Yin B, Li D, Wang G, Han X and Sun X: GSDME mediates caspase-3-dependent pyroptosis in gastric cancer. Biochem Biophys Res Commun. 495:1418–1425. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Akino K, Toyota M, Suzuki H, Imai T, Maruyama R, Kusano M, Nishikawa N, Watanabe Y, Sasaki Y, Abe T, et al: Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci. 98:88–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kim MS, Chang X, Yamashita K, Nagpal JK, Baek JH, Wu G, Trink B, Ratovitski EA, Mori M and Sidransky D: Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 27:3624–3634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang X and Zhang H: Chemotherapy drugs induce pyroptosis through caspase-3-dependent cleavage of GSDME. Sci China Life Sci. 61:739–740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K and Shao F: Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 547:99–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yao L, Li J, Xu Z, Yan Y and Hu K: GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma. Aging (Albany NY). 14:2758–2774. 2022. View Article : Google Scholar : PubMed/NCBI
|
